IMI Members
Sitemap
IMI
- Home
- About IMI
- Ongoing projects
- Ongoing Projects
- Understanding Chronic pain and improving its treatment
- Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes
- SUrrogate markers for Micro- and Macro-vascular hard endpoints for Innovative diabetes Tools
- Physical Activity as a Crucial Patient Reported Outcome in COPD
- Pharmaceutical Medicine Training Programmes
- Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTiumPharmacoepidemiological Research on Outcome
- Integrating bioinformatics and chemoinformatics approaches for the development of expert systems allowing the in silico predicti
- Novel Methods leading to New Medications in Depression and Schizophrenia
- Improving beta-cell function and identification of diagnostic biomarkers for treatment monitoring in diabetes
- Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in early clinical development
- European programme in Pharmacovigilance and Pharmacoepidemiology
- European Modular Education and Training Programme in Safety Sciences for Medicines
- BioMARkers and molecular tumour classification for non-genotoxic CARcinogenesis
- Clinical biomarker qualification via SAFER and FASTER EVIDENCE-BASED TRANSLATION
- European Medicines Research Training Network
- Pilot project InnoMed
- Ongoing Projects
- Call for proposals
- News, Events & Media
- Reference documents
- FAQ
Other subpages
Innovative Medicines Initiative 2010